This piece explores the history; physical, economic, and psychosocial burden; and clinical pathophysiology of type 1 diabetes to evaluate opportunities for earlier intervention to change the standard of care for this disease and improve overall outcomes.
October 20th 2021, 3:14pm
Researchers highlighted the beneficial effects of breastfeeding on mitigating type 1 diabetes (T1D) risk.
October 18th 2021, 4:22pm
Camillo Ricordi, MD, FNAI, outlines what needs to happen next in the islet transplantation field.
October 15th 2021, 6:30pm
Researchers conducted a randomized clinical trial to test the efficacy of a hybrid closed-loop (HCL) system among pediatric patients with type 1 diabetes (T1D).
October 12th 2021, 2:27pm
Camillo Ricordi, MD, FNAI, explains how the outdated FDA classification of islets as cellular transplants has hindered progress in this field for patients with type 1 diabetes.
October 8th 2021, 5:30pm
Leslie Eiland, MD, describes the importance of learning from the COVID-19 pandemic when it comes to ensuring continuous care for those with type 1 diabetes (T1D) during future pandemics.
October 4th 2021, 7:17pm
Throughout, the guidance from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) calls for respecting the patient’s choices, including the fact that not all patients prefer insulin pumps or can afford them.
September 30th 2021, 2:18pm
Results of a 15-year cohort study found waist to height ratio was associated with increased risks of severe diabetic eye disease among individuals with type 1 diabetes.
September 27th 2021, 4:20pm
Ezio Bonifacio, PhD, addresses barriers inhibiting widespread screening for type 1 diabetes (T1D), and offers insights on whether all individuals should be screened, or only those known to be at genetic risk for the disease.
September 23rd 2021, 6:00pm
A team of Australian researchers created and validated a model that may boost efficiency of type 1 diabetes (T1D) progression screening.
September 20th 2021, 12:30pm
Camillo Ricordi, MD, FNAI, discusses some of the potential risks faced by patients with type 1 diabetes who undergo islet transplantation.
